A retrospective study assessing the impact of biological agents on postoperative complications in inflammatory bowel disease
Latest Information Update: 07 Dec 2021
At a glance
- Drugs Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 07 Dec 2021 New trial record